Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

mTORC1 allosteric inhibition and macroautophagy induction

mTORC1 Modulation & Autophagy · Metabolic sensing, autophagy and longevity

Downregulates overactive mTORC1 signaling and lifts its suppression of the ULK1 complex, so that autophagosomes engulf and clear misfolded proteins, β-amyloid and old, damaged mitochondria.

Why it matters: Maintains intracellular protein homeostasis (proteostasis) and clears the cellular “molecular garbage” linked to neurodegenerative disease and aging.

Molecular targets: mTORC1 (Raptor), ULK1, Beclin-1, LC3-II lipidation

Supplements acting on this mechanism (ranked by strength and evidence)

Spermidine

★★★☆☆Mechanism evidence: grade A

Spermidine can promote autophagy in experimental models. In a 2026 randomized, double-blind pilot trial of 40 people, 6 mg/day increased autophagic flux in a specific lymphocyte subset among vaccine non-responders, but not in T cells. The sample is very small, so it cannot be used to infer whole-body autophagy activation, and it does not prove direct inhibition of mTORC1.

Fisetin

★★★☆☆Mechanism evidence: grade C

In some animal models, fisetin changed mTOR and autophagy-related markers, and the direction of the effect varied by model. In a few cell models, autophagy was actually suppressed. Effects on autophagic flux in humans, and whether any effect depends on SIRT1, have not been confirmed.

Green tea extract (EGCG)

★★★☆☆Mechanism evidence: grade C

In cell-free enzyme assays, EGCG can inhibit mTOR by competing with ATP. In mice given it by injection, liver autophagy-related changes appeared, such as more LC3-II and less p62. But these results come from in-vitro work or from animals given injections, and they cannot show that usual oral doses reach free concentrations in human tissue that continuously inhibit mTOR.

Dihydroberberine (DHB)

★★★☆☆Mechanism evidence: grade C

In some mouse models, dihydroberberine can affect mTOR-related signaling, for example the Rheb/mTOR pathway in an ovarian insufficiency model. These results do not directly show that mTORC1 is blocked in humans at usual oral doses, and they do not show that autophagy flux increases.

Trehalose

★☆☆☆☆Mechanism evidence: grade D

In cell and animal studies, trehalose can trigger autophagy and TFEB-related responses, but the concentrations used are far higher than oral dosing can reach in tissue. Some effects are independent of mTOR, and the upstream mechanism is still debated. There is no evidence that oral trehalose induces autophagy in humans.

Scallop plasmalogens

★☆☆☆☆Mechanism evidence: grade D

Changes in amyloid pathology were seen in animal models, but this does not show that mTOR is inhibited or that lysosomal autophagy clears more β-amyloid. There are currently no reliable studies showing that routine oral scallop plasmalogens induce autophagy in humans.

Open in the interactive app ›